Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells
出版年份 2022 全文链接
标题
Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells
作者
关键词
SARS CoV 2, Viral entry, Inflammation, Flow cytometry, Cell staining, COVID 19, Antivirals, Viral replication
出版物
PLoS Pathogens
Volume 18, Issue 1, Pages e1010171
出版商
Public Library of Science (PLoS)
发表日期
2022-01-14
DOI
10.1371/journal.ppat.1010171
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells
- (2021) Shuai Wang et al. CELL RESEARCH
- Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2
- (2021) Tianling Ou et al. PLoS Pathogens
- Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
- (2021) Jose Manuel Condor Capcha et al. Frontiers in Cardiovascular Medicine
- Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
- (2021) Markus Hoffmann et al. EBioMedicine
- SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery
- (2021) Apoorva Mulay et al. Cell Reports
- Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes
- (2021) Neal G. Ravindra et al. PLOS BIOLOGY
- Peripheral and lung resident memory T cell responses against SARS-CoV-2
- (2021) Judith Grau-Expósito et al. Nature Communications
- COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?
- (2020) Gurusaravanan Kutti Sridharan et al. AMERICAN JOURNAL OF THERAPEUTICS
- Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
- (2020) Sangeun Jeon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses
- (2020) Furong Qi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
- (2020) Yixuan J. Hou et al. CELL
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Immunology of COVID-19: current state of the science
- (2020) Nicolas Vabret et al. IMMUNITY
- Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
- (2020) Mingfeng Liao et al. NATURE MEDICINE
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- and Animal Models for SARS-CoV-2 research
- (2020) Kazuo Takayama TRENDS IN PHARMACOLOGICAL SCIENCES
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
- (2020) Mike Bray et al. ANTIVIRAL RESEARCH
- The pharmacological and biological roles of eriodictyol
- (2020) Anowarul Islam et al. ARCHIVES OF PHARMACAL RESEARCH
- Does Ibuprofen Worsen COVID-19?
- (2020) Nicholas Moore et al. DRUG SAFETY
- SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology
- (2020) Natacha S. Ogando et al. JOURNAL OF GENERAL VIROLOGY
- Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2
- (2020) Markus Hoffmann et al. NATURE
- Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates
- (2020) Pauline Maisonnasse et al. NATURE
- Human organoids: model systems for human biology and medicine
- (2020) Jihoon Kim et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- (2020) Moshe Rogosnitzky et al. Pharmacological Reports
- The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)
- (2020) Pere Domingo et al. EBioMedicine
- COVID‐19 infection induces readily detectable morphologic and inflammation‐related phenotypic changes in peripheral blood monocytes
- (2020) Dan Zhang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option
- (2020) Kevin W. Ng et al. NATURE GENETICS
- Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor
- (2020) Olusegun O. Onabajo et al. NATURE GENETICS
- Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent
- (2020) Alexa M. Kaufer et al. PATHOLOGY
- Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
- (2020) Idoia Busnadiego et al. mBio
- Expression of SARS-CoV-2 entry factors in lung epithelial stem cells and its potential implications for COVID-19
- (2020) Anna A. Valyaeva et al. Scientific Reports
- A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality
- (2020) Lucinda Smart et al. INFLAMMOPHARMACOLOGY
- Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract
- (2020) Miguel E. Ortiz et al. EBioMedicine
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- An organoid‐derived bronchioalveolar model for SARS‐CoV‐2 infection of human alveolar type II‐like cells
- (2020) Mart M Lamers et al. EMBO JOURNAL
- Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates
- (2020) M. D. Fahlberg et al. Nature Communications
- Immortalisation of primary human alveolar epithelial lung cells using a non-viral vector to study respiratory bioreactivity in vitro
- (2020) Alberto Katsumiti et al. Scientific Reports
- Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets
- (2020) Robert M. Cox et al. Nature Microbiology
- Extreme heterogeneity of influenza virus infection in single cells
- (2018) Alistair B Russell et al. eLife
- Epithelial MHC Class II Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory Tracts
- (2018) Jonathan E. Wosen et al. Frontiers in Immunology
- Human Lung Mononuclear Phagocytes in Health and Disease
- (2017) Faezzah Baharom et al. Frontiers in Immunology
- Flow-cytometric method for simultaneous analysis of mouse lung epithelial, endothelial, and hematopoietic lineage cells
- (2016) Benjamin D. Singer et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Ibuprofen Attenuates Cardiac Fibrosis in Streptozotocin-Induced Diabetic Rats
- (2015) Weili Qiao et al. CARDIOLOGY
- The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells
- (2015) Mutsuo Yamaya et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Diverse macrophage populations mediate acute lung inflammation and resolution
- (2014) Neil R. Aggarwal et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
- (2013) A. Heurich et al. JOURNAL OF VIROLOGY
- Interleukin-1 Stimulates ADAM17 through a Mechanism Independent of its Cytoplasmic Domain or Phosphorylation at Threonine 735
- (2012) Katherine C. Hall et al. PLoS One
- The Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas receptor axis: A potential target for treating thrombotic diseases
- (2012) Rodrigo Fraga-Silva et al. THROMBOSIS AND HAEMOSTASIS
- Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines
- (2010) Michael A. Whitt JOURNAL OF VIROLOGICAL METHODS
- Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice
- (2008) X. Zhang et al. INFLAMMATION RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started